Akorn Pharma calls it quits and closes all US sites

Earlier this year, one company’s closing is adding to national pharmaceutical shortages and capacity in its bankruptcy. The closing can be construed as more than just allowing a laissez-faire economic policy. There are greater healthcare implications for the US. The nation can rescue banks, companies such as AIG, and those gambling with CDS, countering naked […]